Maison David P, Ching Lauren L, Shikuma Cecilia M, Nerurkar Vivek R
Department of Tropical Medicine, Medical Microbiology, and Pharmacology, University of Hawai i at Mānoa, Honolulu, Hawaii 96813.
Pacific Center for Emerging Infectious Diseases Research, University of Hawai i at Mānoa, Honolulu, Hawaii 96813.
bioRxiv. 2021 Jan 7:2021.01.06.425497. doi: 10.1101/2021.01.06.425497.
COVID-19 pandemic has ravaged the world, caused over 1.8 million deaths in the first year, and severely affected the global economy. Hawaii is not spared from the transmission of SARS-CoV-2 in the local population, including high infection rates in racial and ethnic minorities. Early in the pandemic, we described in this journal various technologies used for the detection of SARS-CoV-2. Herein we characterize a 969-bp SARS-CoV-2 segment of the S gene downstream of the receptor-binding domain. At the John A. Burns School of Medicine Biocontainment Facility, RNA was extracted from an oropharyngeal swab and a nasal swab from two patients from Hawaii who were infected with the SARS-CoV-2 in August 2020. Following PCR, the two viral strains were sequenced using Sanger sequencing, and phylogenetic trees were generated using MEGAX. Phylogenetic tree results indicate that the virus has been introduced to Hawaii from multiple sources. Further, we decoded 13 single nucleotide polymorphisms across 13 unique SARS-CoV-2 genomes within this region of the S gene, with one non-synonymous mutation (P681H) found in the two Hawaii strains. The P681H mutation has unique and emerging characteristics with a significant exponential increase in worldwide frequency when compared to the plateauing of the now universal D614G mutation. The P681H mutation is also characteristic of the new SARS-CoV-2 variants from the United Kingdom and Nigeria. Additionally, several mutations resulting in cysteine residues were detected, potentially resulting in disruption of the disulfide bridges in and around the receptor-binding domain. Targeted sequence characterization is warranted to determine the origin of multiple introductions of SARS-CoV-2 circulating in Hawaii.
新冠疫情肆虐全球,第一年就造成了超过180万人死亡,并严重影响了全球经济。夏威夷当地人群也未能幸免于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的传播,包括少数族裔的高感染率。在疫情早期,我们在本期刊中描述了用于检测SARS-CoV-2的各种技术。在此,我们对受体结合域下游S基因的一段969个碱基对的SARS-CoV-2片段进行了特征分析。在约翰·A·伯恩斯医学院生物防护设施中,从2020年8月感染SARS-CoV-2的两名夏威夷患者的口咽拭子和鼻拭子中提取了RNA。经过聚合酶链反应(PCR)后,使用桑格测序法对这两种病毒株进行了测序,并使用MEGAX生成了系统发育树。系统发育树结果表明,该病毒是从多个来源传入夏威夷的。此外,我们在该S基因区域的13个独特的SARS-CoV-2基因组中解码了13个单核苷酸多态性,在两个夏威夷毒株中发现了一个非同义突变(P681H)。与目前普遍存在的D614G突变趋于平稳相比,P681H突变具有独特且新出现的特征,在全球范围内的频率显著呈指数增长。P681H突变也是来自英国和尼日利亚的新型SARS-CoV-2变体的特征。此外,还检测到了几个导致半胱氨酸残基的突变,这可能会导致受体结合域及其周围的二硫键断裂。有必要进行靶向序列特征分析,以确定在夏威夷传播的SARS-CoV-2多次引入的来源。